At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 20 enrolled
Drug / intervention
Nicotine form +1 moredrug
Likely dose
Nicotine form 36mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Interaction of Flavor With Nicotine Form in Adult Smokers
In Brief
A Phase 1 clinical trial evaluating Nicotine form and E-cigarette experimental flavor for Nicotine Dependence. Completed, enrolled 20 participants across 1 site.
Detailed Summary
This study seeks to elucidate the impact of e-cigarette flavor on subjective effects and nicotine exposure from e-cigarettes containing different forms of nicotine.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNicotine Dependence
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)
Timeline
Phase 1CompletedFinished
2020202120222023202420252026
First PostedFeb 2020
Enrollment StartNov 2020
Primary CompletionJan 2022
Study CompletionFeb 2022
TodayJul 2026
First PostedFeb 10, 2020
Enrollment StartNov 1, 2020
Primary CompletionJan 10, 2022
Study CompletionFeb 2, 2022
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 6.4 years ago
Interventions
Nicotine formdrug
participants will receive 36mg/ml nicotine salt and freebase nicotine
E-cigarette experimental flavorother
Participants will receive menthol and tobacco flavored e-cigarettes